Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
about
Chemically enhanced radiotherapy: visions for the futureNanoparticles for imaging: top or flop?Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imagingNanotargeted radionuclides for cancer nuclear imaging and internal radiotherapyNanotechnology in radiation oncology.Improving chemoradiotherapy with nanoparticle therapeutics.Current advances in polymer-based nanotheranostics for cancer treatment and diagnosisVirosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy.Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.Tumour-targeted nanomedicines: principles and practice.The role of collagen synthesis in ventricular and vascular adaptation to hypoxic pulmonary hypertensionNoninvasive optical imaging of nanomedicine biodistribution.Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatmentImage-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment.High-resolution flow cytometry: a suitable tool for monitoring aneuploid prostate cancer cells after TMZ and TMZ-BioShuttle treatment.Polymer-drug conjugates for novel molecular targets.Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging.Image-guided nanosystems for targeted delivery in cancer therapy.Advances in image-guided intratumoral drug delivery techniques.Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.Liposomes in drug delivery: a patent review (2007 - present).Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.Theranostic nanoparticles for cancer and cardiovascular applications.Programmable nanomedicine: synergistic and sequential drug delivery systems.Applications of nanoparticles for diagnosis and therapy of cancer.Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?Neoantigen activation, protein translocation and targeted drug delivery in combination with radiotherapy.Nanomedicine formulations for combination therapies.T2*-relaxivity contrast imaging: first results.HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations.Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors.HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases.
P2860
Q26767175-8D0A22AD-EA37-4FE8-813D-714063881828Q30429119-56FE7679-D841-4827-BE77-A338B03251EDQ33651804-29D91ED2-6D26-460F-96FE-8062C39B5C3EQ34089324-4676CD23-9C8C-4F11-9B74-E40E9BA0B7DFQ34124280-72784B42-6378-4841-932D-A8AD9861B7DDQ34564219-C8A38AA8-8A7F-4CEE-AA3A-2B3CC4EA87D4Q34783018-6FB4B315-B636-41BD-AF63-8899AA4009F2Q35804205-E3381217-0F22-4E1B-97C9-12FE0AFA1FC5Q36300784-E9F8C5E6-5EA8-4A61-855D-43AFC9243CECQ36858135-721FD675-5F14-4A57-8D33-B467DEAD8983Q36995347-60C9BCB4-B726-4324-8DAC-A365FEE23A8FQ37095731-3B6DABC5-4CAD-40DF-8611-6D54F14756CBQ37206486-9022380F-AEBE-42BC-ACA8-AC3C806A68D8Q37405788-E400982F-4C85-454C-8A1E-4ADA03E22664Q37430234-B9F56DE9-6A73-4CA9-AC99-3D5CAB75FCEFQ37782076-EC7F0661-F3B3-4516-9C44-7E44526AE0F4Q37957956-D8A600D7-005C-42F7-BDA8-56F5FFFE5D3EQ38011794-369448A9-1E1E-4862-9BC9-4C3A82FA1A06Q38027851-09ED64DD-6247-49DA-920C-F3CCA22B825EQ38098301-03BB2CEB-2700-4100-B283-E4C7216F7C4FQ38129924-6C899A76-9B14-4EEC-964D-742273027FBEQ38133484-FB61C613-222C-48CE-BB3C-4C2F658697F2Q38193333-053A4767-7E5F-4C39-A418-F1427F408118Q38336134-181BE915-F13E-4377-B210-BB25EC4EF82BQ38477152-8FE57758-4BF2-405E-96F0-EEFF61BAD513Q38755295-374B6927-8381-4E9A-B400-C663FBA48342Q38850501-53E1794D-218F-4081-93A0-BFAF64917258Q39078409-469B3E37-E70E-4C0F-9264-047124EB138AQ39325108-D7289572-1033-4C95-8345-DA172F55D27DQ42782242-B62142B5-6728-42DF-893F-FDCC5CE6AE8EQ48724706-C082099D-9F2D-4EA9-8962-FC72D49CA7E2Q53416548-8021D3E0-0895-4E59-8236-4A62ED612B9D
P2860
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
@en
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
@nl
type
label
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
@en
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
@nl
prefLabel
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
@en
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
@nl
P2093
P2860
P356
P1476
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
@en
P2093
F Kiessling
M Heilmann
R Kühnlein
W E Hennink
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604561
P407
P577
2008-09-01T00:00:00Z